Ilić, T.; Đoković, J.B.; Nikolić, I.; Mitrović, J.R.; Pantelić, I.; Savić, S.D.; Savić, M.M.
Parenteral Lipid-Based Nanoparticles for CNS Disorders: Integrating Various Facets of Preclinical Evaluation towards More Effective Clinical Translation. Pharmaceutics 2023, 15, 443.
https://doi.org/10.3390/pharmaceutics15020443
AMA Style
Ilić T, Đoković JB, Nikolić I, Mitrović JR, Pantelić I, Savić SD, Savić MM.
Parenteral Lipid-Based Nanoparticles for CNS Disorders: Integrating Various Facets of Preclinical Evaluation towards More Effective Clinical Translation. Pharmaceutics. 2023; 15(2):443.
https://doi.org/10.3390/pharmaceutics15020443
Chicago/Turabian Style
Ilić, Tanja, Jelena B. Đoković, Ines Nikolić, Jelena R. Mitrović, Ivana Pantelić, Snežana D. Savić, and Miroslav M. Savić.
2023. "Parenteral Lipid-Based Nanoparticles for CNS Disorders: Integrating Various Facets of Preclinical Evaluation towards More Effective Clinical Translation" Pharmaceutics 15, no. 2: 443.
https://doi.org/10.3390/pharmaceutics15020443
APA Style
Ilić, T., Đoković, J. B., Nikolić, I., Mitrović, J. R., Pantelić, I., Savić, S. D., & Savić, M. M.
(2023). Parenteral Lipid-Based Nanoparticles for CNS Disorders: Integrating Various Facets of Preclinical Evaluation towards More Effective Clinical Translation. Pharmaceutics, 15(2), 443.
https://doi.org/10.3390/pharmaceutics15020443